These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2104439)

  • 1. [Various parameters of lipid metabolism after intra-arterial injections of ozone in patients with ischemia of the lower extremities and diabetes mellitus].
    Sroczyński J; Antoszewski Z; Rudzki H; Matyszczyk B; Kuźniewicz R
    Pol Tyg Lek; 1990 Nov 19-26; 45(47-48):953-5. PubMed ID: 2104439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hemostasis and lipid metabolism in patients with non-insulin- dependent diabetes mellitus and angiopathy of the lower extremities].
    Mamedgasanov RM; Semavin IE; Smirnova LM; Rudenko GR; Riazanov IuI
    Klin Med (Mosk); 1989 Aug; 67(8):74-6. PubMed ID: 2811244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ozone therapy and viscosity of blood and plasma, distance of intermittent claudication and certain biochemical components in patients with diabetes type II and ischemia of the lower extremities].
    Turczyński B; Sroczyński J; Antoszewski Z; Matyszczyk B; Krupa G; Młynarski J; Strugala M
    Pol Tyg Lek; 1991 Sep 9-30; 46(37-39):708-10. PubMed ID: 1669138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of low-density lipoprotein apheresis on plasma matrix metalloproteinase-9 and serum tissue inhibitor of metalloproteinase-1 levels in diabetic hemodialysis patients with arteriosclerosis obliterans.
    Nakamura T; Matsuda T; Suzuki Y; Ueda Y; Koide H
    ASAIO J; 2003; 49(4):430-4. PubMed ID: 12918586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of proinflammatory cytokines in chronic lower limb ischaemia diabetic macroangiopathy and arteriosclerosis obliterans].
    Zdrojowy K; Knapik-Kordecka M; Jakobsche-Policht U; Adamiec R
    Pol Merkur Lekarski; 2009 Dec; 27(162):458-62. PubMed ID: 20120706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [An evaluation of the results of intra-arterial injections in treating chronic ischemia of the lower extremities].
    Prokhorov GG
    Vestn Khir Im I I Grek; 1991; 147(7-8):41-4. PubMed ID: 1668930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Incidence of diabetes in patients with arteriosclerotic occlusive disease of the legs].
    Mayrhofer E; Klieber M
    Wien Klin Wochenschr; 1972 Dec; 84(52):843-6. PubMed ID: 4651913
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical assessment of treatment results for atherosclerotic ischemia of the lower extremities with intraarterial ozone injections].
    Sroczyński J; Antoszewski Z; Matyszczyk B; Krupa G; Rudzki H; Zbrońska H; Skowron J
    Pol Tyg Lek; 1992 Oct 19-26; 47(42-43):964-6. PubMed ID: 1300589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematologic changes in type 2 diabetic patients with various localizations of peripheral vascular disease.
    Tkác I; Tkácová R; Takác M; Lazúr J
    Vasa; 1992; 21(4):360-4. PubMed ID: 1485469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of glibenclamide on lipid metabolism in non-insulin-dependent diabetic patients].
    Ratzmann KP; Schimke E; Herrmann C; Borngräber G; Meusel K
    Z Gesamte Inn Med; 1988 Mar; 43(5):122-4. PubMed ID: 3133890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diseases of the blood vessels of the lower extremities in diabetes mellitus].
    Gevorkian IKh; Akhverdian RA; Aslanian RA
    Khirurgiia (Mosk); 1973 Aug; 49(8):16-20. PubMed ID: 4760202
    [No Abstract]   [Full Text] [Related]  

  • 12. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Level of certain prostanoids in serum of patients treated with ozone injected intra-arterially].
    Bujak EM; Bodzenta E
    Pneumonol Alergol Pol; 1994; 62 Suppl 1():77-82. PubMed ID: 8049671
    [No Abstract]   [Full Text] [Related]  

  • 14. [Blood lipids and glucose tolerance in 100 patients with arteriosclerotic occlusions in the lower extremities].
    Beyrer K; May R; Sailer S
    Wien Klin Wochenschr; 1968 May; 80(20):392-4. PubMed ID: 5728030
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of policosanol and lovastatin on lipid profile and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus.
    Castaño G; Menéndez R; Más R; Amor A; Fernández JL; González RL; Lezcay M; Alvarez E
    Int J Clin Pharmacol Res; 2002; 22(3-4):89-99. PubMed ID: 12837046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Disorders of lipid metabolism in diabetes mellitus].
    Biesenbach G
    Wien Med Wochenschr Suppl; 1989; 105():9-17. PubMed ID: 2694631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of plant sterols or stanols on lipid parameters in patients with type 2 diabetes: a meta-analysis.
    Baker WL; Baker EL; Coleman CI
    Diabetes Res Clin Pract; 2009 May; 84(2):e33-7. PubMed ID: 19243852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol-lowering effects of rosuvastatin compared with atorvastatin in patients with type 2 diabetes -- CORALL study.
    Wolffenbuttel BH; Franken AA; Vincent HH;
    J Intern Med; 2005 Jun; 257(6):531-9. PubMed ID: 15910557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term (18-month) efficacy of atorvastatin therapy in type 2 diabetics at cardiovascular risk.
    Velussi M
    Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):29-35. PubMed ID: 12125227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term effect of buformin, a biguanide, on insulin sensitivity, soluble fraction of tumor necrosis factor receptor and serum lipids in overweight patients with type 2 diabetes mellitus.
    Ohara S; Komatsu R; Matsuyama T
    Diabetes Res Clin Pract; 2004 Nov; 66(2):133-8. PubMed ID: 15533580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.